| | | | | |
ANIK Anika Therapeutics Inc | €18,6926 | +0,79% | €254,67M | €75,17K | |
BACC Blue Acquisition Corp. Class A Ordinary Shares | €9,0353 | -0,66% | €254,59M | €345,52 | |
GPAC General Purpose Acquisition Corp. Class A Ordinary Shares | €8,6726 | +0,00% | €254,55M | €4,34K | |
BPRN Princeton Bancorp, Inc. Common Stock (PA) | €37,1434 | +0,56% | €254,41M | €26,66K | |
| €38,9703 | +0,41% | €254,26M | €14,41K | |
ACGC ACP Holdings Acquisition Corp. Class A Ordinary Shares | €8,6544 | +0,19% | €254,26M | €86,39K | |
HCAC Hall Chadwick Acquisition Corp Class A Ordinary Shares | €8,6985 | -0,10% | €254,24M | €164,12 | |
SLN Silence Therapeutics Plc American Depository Share | €12,1623 | -1,88% | €254,19M | €1,28M | |
MTNE CH4 Natural Solutions Corporation | €8,5300 | +0,04% | €253,86M | €124,38 | |
RXST RxSight, Inc. Common Stock | €5,5024 | -1,70% | €253,65M | €615,48K | |
NHIC NewHold Investment Corp III Class A Ordinary shares | €9,1908 | +0,00% | €253,54M | €100,05K | |
IRHO Iron Horse Acquisitions II Corp. Common Stock | €8,6423 | -0,10% | €253,51M | €74,72K | |
CNXU Conexeu Sciences Inc. Common Stock | €8,6380 | +2,25% | €253,32M | €348,87K | |
| €8,6294 | -2,73% | €253,07M | €1,02M | |
JCE Nuveen Core Equity Alpha Fund | €14,7537 | -0,76% | €252,90M | €19,95K | |
